Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRCA Verrica Pharmaceuticals Inc.

盘前交易 08-21 04:45:17 EDT

4.86

-0.13

-2.61%

最高5.18	最低4.83	成交量13.85万
今开4.99	昨收4.99	日振幅7.04%
总市值8,349万	流通市值3,294万	总股本1,718万
成交额68.91万	换手率2.04%	流通股本677.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":4.86,"timestamp":1787256000000,"preClose":4.99,"halted":0,"volume":138467,"delay":0,"changeRate":-0.02605210420841681,"floatShares":6777400,"shares":17178800,"eps":-1.74,"marketStatus":"盘前交易","change":-0.13,"latestTime":"08-21 04:45:17 EDT","open":4.99,"high":5.1811,"low":4.83,"amount":689066.763399,"amplitude":0.070361,"askPrice":5,"askSize":1,"bidPrice":4.39,"bidSize":42,"shortable":3,"etf":0,"ttmEps":-1.74,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787319000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":4.86,"postHourTrading":{"tag":"盘后","latestPrice":5.04,"preClose":4.86,"latestTime":"19:56 EDT","volume":775,"amount":3860.29,"timestamp":1787270196029,"change":0.18,"changeRate":0.037037,"amplitude":0.037037},"volumeRatio":1.3424157685550189,"impliedVol":0.3196,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VRCA","defaultTab":"news","newsList":[{"id":"1101200146","title":"Verrica Pharmaceuticals 获得最高2750万美元非稀释性信贷额度，助力增长战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1101200146","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101200146?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:02","pubTimestamp":1786046539,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（股票代码：VRCA）近日宣布，其已成功完成一笔最高达2750万美元的信贷融资安排。这笔资金被定位为非稀释性的增长资本，意味着公司无需通过发行新股来获取资金，从而避免了对现有股东权益的摊薄。此举为公司的长远发展注入了强劲的财务动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115517449","title":"Verrica Pharmaceuticals 将于2026年8月6日披露第二季度财报并发布公司最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1115517449","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115517449?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:01","pubTimestamp":1785412886,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（股票代码：VRCA）宣布，计划于2026年8月6日公布其第二季度财务业绩，并同步向市场提供公司业务的最新进展信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179168629","title":"Verrica制药公司：将获得Medomie在以色列销售产品净售价的60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179168629","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179168629?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:07","pubTimestamp":1784635622,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 宣布，公司将获得其合作伙伴Medomie在以色列市场所销售相关产品的净售价的60%。此项协议明确了双方在特定区域内的收益分配机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151669648","title":"Verrica Pharmaceuticals Inc. 有资格获得总计高达820万美元的监管与商业里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1151669648","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151669648?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:03","pubTimestamp":1784635413,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 已符合条件，可获取总计高达820万美元的监管及商业里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165758477","title":"Verrica制药与Medomie Pharma达成独家分销、营销与供应协议，在以色列商业化Ycanth®用于治疗传染性软疣","url":"https://stock-news.laohu8.com/highlight/detail?id=1165758477","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165758477?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635300,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 与 Medomie Pharma已签署一项独家分销、营销及供应协议，旨在以色列市场推出Ycanth®，用于治疗传染性软疣。该协议授权Medomie Pharma在以色列境内独家负责Ycanth®的商业化活动，包括分销、市场推广及供应链管理。Ycanth®是Verrica公司开发的一款针对传染性软疣的处方疗法。此次合作旨在扩大该疗法在中东地区的可及性，满足当地患者的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164626689","title":"Verrica制药授予Medomie在以色列独家获取及维持Ycanth营销授权的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1164626689","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164626689?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:01","pubTimestamp":1784635300,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 已授予Medomie公司在以色列独家获取并维持其产品Ycanth营销授权的权利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180761833","title":"Verrica Pharmaceuticals宣布其3期项目评估Ycanth®治疗寻常疣的第二项关键临床试验首位美国患者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1180761833","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180761833?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:08","pubTimestamp":1782130131,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. (VRCA) 宣布，其针对Ycanth® (Vp-102) 治疗寻常疣的3期项目中的第二项关键临床试验（Cove-3）已为首位美国患者完成首次给药。这一进展标志着该公司在推进该潜在疗法用于治疗这一常见皮肤病的临床开发进程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110914018","title":"Verrica制药将在2026年皮肤病研究学会年会公布VP-315治疗基底细胞癌潜在远端效应的二期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1110914018","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110914018?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:10","pubTimestamp":1778011807,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（VRCA）宣布，将于2026年皮肤病研究学会（SID）年会上展示其候选药物VP-315治疗基底细胞癌的二期临床试验数据。该报告将重点阐释VP-315可能引发的\"远端效应\"——这一现象意味着局部治疗不仅作用于目标病灶，还可能对远离治疗区域的癌细胞产生抑制效果。\n此次数据披露备受业界关注，因其可能为皮肤癌治疗开辟新的途径。远端效应的验证将进一步提升VP-315作为创新疗法的科学价值与市场潜力。公司表示，这项研究成果有望为晚期基底细胞癌患者提供更有效的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122819042","title":"Verrica制药公司将于2026年5月12日公布2026年第一季度财务业绩并发布业务进展报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1122819042","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122819042?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:01","pubTimestamp":1777982484,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（简称Verrica制药）宣布，计划于2026年5月12日发布其2026年第一季度的财务业绩。届时，公司管理层还将同步提供最新的业务进展与战略更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618390891","title":"Verrica制药股价重挫14.05% 市值跌1154.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618390891?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:31","pubTimestamp":1773235862,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时31分，Verrica制药股票出现异动，股价急速下跌14.05%。截至发稿，该股报5.14美元/股，成交量2.1518万股，换手率0.13%，振幅1.51%。最近的财报数据显示，该股实现营业收入14.34百万美元，净利润-274000.00美元，每股收益-0.03美元，毛利13.24百万美元，市盈率-1.79倍。Verrica制药股票所在的生物技术行业中，整体跌幅为0.08%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311213102a46169a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311213102a46169a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190033327","title":"Verrica制药公司：推进VP-315于2026年进入基底细胞癌三期临床试验计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1190033327","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190033327?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:16","pubTimestamp":1773231367,"startTime":"0","endTime":"0","summary":"Verrica制药公司正积极推进其候选药物VP-315的开发进程。该药物针对基底细胞癌的治疗，预计将在2026年进入关键的第三阶段临床试验计划。这一进展标志着公司在皮肤病治疗领域的重要步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114940124","title":"Verrica Pharmaceuticals计划与Torii制药于2026年中启动Ycanth在美国和日本的第二阶段3期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1114940124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114940124?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:14","pubTimestamp":1773231253,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（简称：Verrica）宣布，公司预计将于2026年中期与Torii Pharmaceutical合作，在美国和日本启动其候选药物Ycanth的第二项3期临床试验。这一进展标志着Ycanth在治疗领域的开发进程迈出重要一步，为后续市场拓展奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184224158","title":"Verrica Pharmaceuticals Inc. 将于2026年3月11日公布2025年第四季度及全年财务业绩并发布公司最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1184224158","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184224158?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:04","pubTimestamp":1772715849,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 宣布，计划于2026年3月11日发布其2025年第四季度及全年的财务业绩报告。届时，公司管理层还将提供最新的业务进展和公司战略更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227291","title":"Verrica制药盘中异动 临近午盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227291?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:46","pubTimestamp":1741621565,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时46分，Verrica制药股票出现异动，股价急速上涨5.30%。截至发稿，该股报0.640美元/股，成交量13.9209万股，换手率0.15%，振幅7.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.14%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677013","title":"Verrica制药盘中异动 早盘股价大跌7.44%报0.593美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677013?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:46","pubTimestamp":1741099583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时46分，Verrica制药股票出现波动，股价快速下跌7.44%。截至发稿，该股报0.593美元/股，成交量9.0819万股，换手率0.10%，振幅11.19%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.36%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378122","title":"Verrica制药盘中异动 早盘股价大涨5.07%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514378122?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Verrica制药股票出现异动，股价大幅上涨5.07%。截至发稿，该股报0.620美元/股，成交量7287股，换手率0.01%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.02%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007","VRPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514380226","title":"Verrica制药盘中异动 股价大跌6.70%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514380226?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:01","pubTimestamp":1740675685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时01分，Verrica制药股票出现异动，股价急速下跌6.70%。截至发稿，该股报0.662美元/股，成交量12.3952万股，换手率0.14%，振幅6.39%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.40%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514685274","title":"Verrica制药盘中异动 快速拉升6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514685274?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:06","pubTimestamp":1740585987,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时06分，Verrica制药股票出现波动，股价急速拉升6.04%。截至发稿，该股报0.720美元/股，成交量4.6793万股，换手率0.05%，振幅4.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.19%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270006279631619d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514726687","title":"Verrica制药盘中异动 大幅下跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514726687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514726687?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:16","pubTimestamp":1740421006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时16分，Verrica制药股票出现异动，股价急速下挫5.27%。截至发稿，该股报0.697美元/股，成交量11.4309万股，换手率0.13%，振幅8.68%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.37%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225021646962ec798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512481564","title":"Verrica制药盘中异动 急速下跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481564?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:52","pubTimestamp":1739980334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时52分，Verrica制药股票出现异动，股价大幅下挫6.04%。截至发稿，该股报0.689美元/股，成交量10.3381万股，换手率0.11%，振幅8.64%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.55%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235214988b3e3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.verrica.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1066},{"period":"3month","weight":-0.198},{"period":"6month","weight":-0.1606},{"period":"1year","weight":-0.1259},{"period":"ytd","weight":-0.4152}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verrica Pharmaceuticals Inc.于2013年7月3日根据特拉华州法律注册成立。该公司是一家开发和商业化用于皮肤病（包括皮肤癌）的临床施用治疗药物的公司。其商业化产品YCANTH已获批用于治疗传染性软疣，研发管线中还包括针对寻常疣和基底细胞癌的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.064974},{"month":2,"riseRate":0.5,"avgChangeRate":0.04305},{"month":3,"riseRate":0.25,"avgChangeRate":-0.05513},{"month":4,"riseRate":0.5,"avgChangeRate":0.011304},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134822},{"month":6,"riseRate":0.625,"avgChangeRate":0.074464},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.005586},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.047361},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080364},{"month":10,"riseRate":0.125,"avgChangeRate":-0.088008},{"month":11,"riseRate":0.5,"avgChangeRate":0.227615},{"month":12,"riseRate":0.375,"avgChangeRate":0.021484}],"exchange":"NASDAQ","name":"Verrica Pharmaceuticals Inc.","nameEN":"Verrica Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verrica Pharmaceuticals Inc.,VRCA,Verrica Pharmaceuticals Inc.股票,Verrica Pharmaceuticals Inc.股票老虎,Verrica Pharmaceuticals Inc.股票老虎国际,Verrica Pharmaceuticals Inc.行情,Verrica Pharmaceuticals Inc.股票行情,Verrica Pharmaceuticals Inc.股价,Verrica Pharmaceuticals Inc.股市,Verrica Pharmaceuticals Inc.股票价格,Verrica Pharmaceuticals Inc.股票交易,Verrica Pharmaceuticals Inc.股票购买,Verrica Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}